IHS Chemical Week

Regions :: North America :: U.S.

Lonza Signs Manufacturing Deal with Femta Pharmaceuticals

10:22 PM MST | December 15, 2009 | Deepti Ramesh

Lonza says it has signed a manufacturing services agreement with Femta Pharmaceuticals (San Diego, CA), to facilitate the development and manufacturing of FM101, a high affinity monoclonal antibody in late pre-clinical development for the treatment of rheumatoid arthritis. The agreement gives Femta access to Lonza’s GS Gene Expression System along with cell line, purification and process development to support a cGMP process for Femta’s clinical development program. “By leveraging Lonza’s considerable expertise in gene expression and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa